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Scheme A.   Syntheses of TyrO3P, TyrO3S, TyrO3T, and TyrO3Q precursors; compounds 1, 2, 3, and 4, respectively.  Cyanomethyl esters 1, 2 , 3,
and 4 are prepared for coupling to dCA and subsequent  enzymatic ligation to tRNA.  The synthesis of 4 has been published previously.1
S2
Experimental Procedures
General.   Reagents were purchased from Aldrich, Sigma,
or other commercial sources.  TMB-8 was purchased from RBI
(Natick, MA).  ACh chloride and QX-314 were purchased from
Sigma.  Anhydrous THF and methylene chloride were
obtained from J. T. Baker solvent kegs; anhydrous DMF
(Puris) was obtained from Fluka.  Flash chromatography was
on 230-400 mesh silica gel with the solvent indicated.  All
NMR shifts are reported as δ ppm downfield from TMS.  1H
NMR and 13C NMR spectra were recorded at 300 MHz in
CDCl3 or CD3CN using a Varian QE-300 spectrometer.
Electrospray (ESI) ionization and matrix-assisted laser-
desorbed ionization (MALDI) quadrupole mass spectrometry
was performed at the Caltech Protein/Peptide Micro
Analytical Laboratory or at the Caltech Division of
Chemistry and Chemical Engineering Mass Spectrometry
Facility.  Nitroveratryloxycarbonyl chloride (NVOCCl),
NVOC-Tyrosine t-butyl ester (NVOC-Tyr-OtBu, 6), and
NVOC-Tyrosine-O-propylbromide t-butyl ester (NVOC-
TyrO3Br-OtBu, 7) were prepared as previously described.1
N -NVOC-Bromopropylamine ( 1 0 ) .   0.15 g 3-
bromopropylamine were dissolved in 15 mL p-dioxane and
15 mL water.  0.11 g Na2CO3 were dissolved in 15 mL water.
3-bromopropylamine solution was combined with the
Na2CO3 solution.  0.19 g NVOC-Cl were completely
dissolved in 25 mL dioxane, and were added to the other
mixture and stirred for 1 h. The reaction mixture was extracted
with 3 X 25 mL CH2Cl2, the organic layers were combined,
dried with sodium sulfate, and run on a column in methylene
chloride to give 0.25 g (37%) of product.  1H NMR (CDCl3):
δ 7.66 (s, 1H), 6.97 (s, 1H), 5.46 (s, 2H), 5.16 (br s, 1H),
3.95 (s, 3H), 3.92 (s, 3H), 3.43 (t, J=6.3 Hz, 2H), 3.36 (td,
J=6.3 Hz, 6.3 Hz, 2H), 2.07 (m, 2H);  13C NMR (CDCl3):
155.7, 153.2, 147.8, 127.7, 110.1, 107.9, 63.5, 56.3,
56.3, 39.4, 32.3, 30.6.
NVOC-TyrO3P(NVOC)-OtBu ( 1 3 ) .   To a mixture of
0.12 g NVOC-Tyr-OtBu and 0.166 g Cs2CO3 (two equivalents)
dissolved in 10 mL DMF were added 0.096 g N-NVOC-
bromopropylamine in 13 mL of anhydrous DMF, under Ar.
After the reaction was stirred for 1.5 hours, the reaction
mixture was extracted using 3 X 25 mL methylene chloride,
the organic layers were combined, dried with sodium sulfate,
and run on a flash column in 1:1 petroleum ether / ethyl
acetate to give 75 mg (38%) of product.  1H NMR (CDCl3):  δ
7.70 (s, 1H), 7.49 (s, 1H), 7.08 (d, J=4.2 Hz, 2H), 7.00 (s,
1H), 6.97 (s, 1H), 6.81 (d, J=4.2 Hz, 2H), 5.52 and 5.47 (AB,
J=11.4 Hz, 11.4 Hz, 2H), 5.50 (s, 2H), 5.41 (d, 1H), 5.26 (br
s, 1H), 4.52 (m, 1H), 4.02 (t, J=5.7 Hz, 2H), 4.98 (s, 3H),
4.98 (s, 3H), 4.98 (s, 3H), 4.98 (s, 3H), 3.44 (dt, J=6.3 Hz,
6.3 Hz, 2H), 3.05 (m, 2H), 2.02 (m, 2H), 1.44 (s, 9H); 13C
NMR (CDCl3): 170.4, 157.4, 155.7, 155.0, 153.4, 153.2,
147.7, 147.5, 141.0, 139.2, 130.2, 128.1, 128.0, 114.2,
114.0, 109.9, 109.5, 107.9, 107.9, 82.3, 65.6, 63.6, 63.4,
56.4, 56.3, 56.1, 55.2, 38.7, 37.2, 29.3, 27.9.
NVOC-TyrO3P(NVOC)-OCH2CN (1 ) .   0.075 g
NVOC-Tyr-O3P(NVOC)-OtBu were dissolved in 5 mL
methylene chloride.  3 mL TFA were added to the mixture,
using a glass pipette.  The reaction was stirred for 1 hour.
Volatiles were removed on the vacuum pump with a dry
ice/acetone trap.  10 mL anhydrous DMF, 5 mL
chloroacteonitrile, and 1 mL diisopropylethylamine (DIPEA)
were added to the flask, under argon.  After the reaction was
stirred for 3 hours, the volatiles in the mixture were removed
on the vacuum pump with a dry ice/acetone trap.  The reaction
mixture was run on a silica column in 1:1 petroleum ether /
ethyl acetate to give 53 mg (72%) product.  1H NMR (CDCl3):
7.70 (s, 1H), 7.70 (s, 1H), 7.07 (d, J=4.2 Hz, 2H), 7.01 (s,
1H), 6.94 (s, 1H), 6.85 (d, J=4.2 Hz, 2H), 5.53 and 5.50 (AB,
J=14.7 Hz, 14.8 Hz, 2H), 5.50 and 5.47 (AB, J=15.1 Hz,
14.7 Hz, 2H), 5.41 (s, 1H), 5.28 (d, J=6.3 Hz, 1H), 4.78 and
4.70 (AB, J=21.3 Hz, 21.3 Hz, 2H), 4.69 (m, 1H), 4.03 (t,
J=5.7 Hz, 2H), 3.95 (s, 3H), 3.95 (s, 3H), 3.95 (s, 3H), 3.95
(s, 3H), 3.44 (dt, J=6.3 Hz, 6.3 Hz, 2H), 3.10 (m, 2H, J=6.3
Hz, 6.3 Hz), 2.02 (m, J=6.3 Hz, 2H); 13C NMR (CDCl3):
170.2, 157.8, 155.7, 155.0, 153.3, 153.2, 147.8, 147.6,
141.0, 139.4, 130.0 127.9, 127.4, 126.7, 114.6, 113.5,
110.0, 109.8, 107.9, 65.6, 64.0, 63.4, 56.4, 56.2, 56.3,
56.1, 54.8, 48.9, 38.6, 36.9, 29.7, 29.2.
NVOC-TyrO3S-OtBu ( 1 1 ) .   268 mg NVOC-TyrO3Br-
OtBu were dissolved in 20 mL anhydrous THF under Ar in a 3-
neck round-bottom flask with a CO2(s) / acetone condenser.
This was cooled to - 20 °C in a 30% KCl / ice bath and then
NH2Me gas was bubbled through the solution until the drip
rate from the condenser tip was about 2 s-1.  The setup was
allowed to warm to RT and then the reaction mixture was
rotoevaporated to ensure removal of the dissolved NH2Me.
Chromatographic purification was achieved by elution of the
starting material in CH2Cl2 followed by collection of the
product in CH2Cl2 with  5% triethylamine.  164 mg of flaky
yellow solid (67%) were obtained in this manner.  1H NMR
(CDCl3)  δ 7.67 (s, 1H), 7.09 (d, J = 8.5 Hz, 2H), 6.96 (s,
1H), 6.81 (d, J = 8.5 Hz, 2H), 5.81 (d, J = 8.1 Hz, 1H), 5.52
and 5.44 (AB, J = 15.2 Hz, 2H), 4.49 (m, 1H), 3.99 (t, J = 6.3
Hz, 2H), 3.95 (s, 3H), 3.93 (s, 3H), 3.03 (m, 2H), 2.75 (t, J =
6.9 Hz, 2H), 2.44 (s, 3H), 1.95 (m, 2H), 1.43 (s, 9H)
NVOC-TyrO3S(NVOC)-OtBu ( 1 4 ) .   65 mg Na2CO3
(2 equiv.) were dissolved in 15 mL water and added to a
solution of 164 mg NVOC-TyrO3S-OtBu in 15 mL p-dioxane.
168 mg NVOC-Cl (2 equiv.) in 15 mL p-dioxane were added to
this and the reaction was stirred overnight.  The product was
purified by flash chromatography in 1:1 EtOAC / petroleum
ether, giving 104 mg (44%) of a dark yellow solid.  1H NMR
(CDCl3)  δ 7.72 (s, 1H), 7.68 (s, 1H), 7.07 (d, J = 8.4 Hz,
2H), 7.03 (s, 1H), 7.01 (s, 1H), 6.79 (d, J = 8.4 Hz, 2H), 5.56
and 5.51 (AB, J = 15.0 Hz, 2H), 5.47 (br s, 2H), 5.35 (d, J =
7.5 Hz, 1H), 4.51 (m, 1H), 3.96 (br t, J = 6.3 Hz, 2H), 3.95
(s, 3H), 3.95 (s, 3H), 3.95 (s, 3H), 3.95 (s, 3H), 3.52 (t, J =
12.5 Hz, 2H), 3.05 (m, 2H), 3.00 (d, J = 17.5 Hz, 2H), 2.05
(m, 2H), 1.44 (s, 9H)
NVOC-TyrO3S(NVOC)-OCH2CN (2 ) .   After 64 mg
NVOC-TyrO3S(NVOC)-OtBu were stirred with 1.00 mL
trifluoroacetic acid for 1 hr. in 10 mL CH2Cl2, the reaction
mixture was pumped on for 2 h. with a dry ice / acetone trap.
The crude amino acid was coevaporated with toluene and
redissolved in 10 mL DMF under Ar for esterification.  0.50
mL chloroacetonitrile was added with 0.10 mL DIPEA and the
mixture was stirred at RT.  The next morning, the volatiles
were removed under vacuum and the mixture was run on a
column in 3:1 petroleum ether / EtOAc.  24 mg of an orange
solid were obtained in a 40% yield.  1H NMR (CDCl3)  δ 7.70
(s, 1H), 7.67 (s, 1H), 7.07 (d, J = 8.4 Hz, 2H), 7.03 (s, 1H),
6.99 (s, 1H), 6.81 (d, J = 8.4 Hz, 2H), 5.55 and 5.49 (AB, J =
15.1 Hz, 2H), 5.47 (br d, J = 15.1 Hz, 2H), 5.33 (d, J = 7.5
Hz, 1H), 4.98 (br s, 2H), 4.38 (m, 1H), 3.97 (br t, J = 6.3 Hz,
2H), 3.94 (s, 3H), 3.94 (s, 3H), 3.94 (s, 3H), 3.94 (s, 3H),
S3
3.56 (t, J = 10.5 Hz, 2H), 3.04 (m, 2H), 2.98 (d, J = 16.0 Hz,
2H), 2.08 (m, 2H), 1.46 (s, 9H)
4PO-Tyr-OtBu (8 ) .   148 mg Na2CO3 (1.4 equiv.) were
stirred with 237 mg Tyr-OtBu in 25 mL H2O and 20 mL p-
dioxane.  256 µL 4-pentenoic anhydride (4P) anhydride, 2 .1
equiv., Aldrich), dissolved in 5 mL p-dioxane, were added.
The reaction was quenched after 1 hr. with 25 mL each CH2Cl2
and 1 M NaHSO4.  The aqueous layer was extracted with 3 X 25
mL CH2Cl2 and purified on a column in 3:1 petroleum ether /
EtOAc.  249 mg of an oily yellow solid obtained in a 73%
yield.  1H NMR (CDCl3)  δ 6.90 (d, J = 8.4 Hz, 2H), 6.68 (d, J
= 8.5 Hz, 2H), 6.21 (d, J = 6.6 Hz, 1H), 5.66 (m, 1H), 4.94
(d, J = 18.0 Hz, 1H), 4.89 (d, J = 11.2 Hz, 1H), 4.66 (m, 1H),
2.90 (m, 2H), 2.18 (m, 2H), 2.21 (m, 2H), 1.37 (s, 9H)  13C
NMR (CDCl3): 171.6, 171.2, 155.6, 139.3, 130.5, 128.5,
115.5, 114.5, 82.6, 53.4, 37.5, 35.7, 32.6, 28.2.
4PO-TyrO3Br-OtBu (9 ) .   750 mg Cs2CO3 (2 equiv.)
were combined with 2.00 mL 1,3-dibromopropane in 20 mL
dry DMF in a flame-dried flask under Ar.  249 mg 4PO-Tyr-
OtBu were dissolved in 10 mL DMF under Ar, added to the
Cs2CO3 slurry through a septum, and stirred overnight.  The
reaction mixture was stirred 10 min. with 30 mL water and
extracted with 3 X 25 mL CH2Cl2.  Flash chromatography of
the combined organics with 3:1 petroleum ether / EtOAc gave
157 mg of sticky yellow solid, a 47% yield.  1H NMR (CDCl3)
δ 7.00 (d, J = 8.9 Hz, 2H), 6.75 (d, J = 8.7 Hz, 2H), 6.24 (d, J
= 6.8 Hz, 1H), 5.68 (m, 1H), 4.96 (d, J = 17.9 Hz, 1H), 4.91
(d, J = 11.3 Hz, 1H), 4.67 (m, 1H), 3.99 (t, J = 5.8 Hz, 2H),
3.51 (t, J = 6.6 Hz, 2H), 2.94 (m, 2H), 2.27 (m, 2H), 2.23
(m, 2H), 2.20 (m, 2H), 1.36 (s, 9H)  13C NMR (CDCl3):
171.8, 171.1, 157.8, 137.1, 130.7, 128.7, 115.7, 114.5,
82.4, 65.5, 53.8, 37.5, 35.9, 32.7, 30.4, 29.7, 28.3.
4PO-TyrO3T-O tBu (12).  236 mg 4PO-TyrO3Br-OtBu
were dissolved in 25 mL dry THF in a 3-neck round-bottom
flask with a dry ice / acetone condenser under Ar.  The setup
was cooled in ice and NH(Me)2 gas was bubbled through the
yellow solution until it was dripping vigorously from the
condenser tip.  The cooling apparatus was maintained for 2
hrs. and then the reaction mixture was allowed to warm to RT.
After rotoevaporation to remove the volatile components,
the mixture was chromatographed.  Starting material was
eluted with EtOAc and then the product was collected with 5%
triethylamine in CH2Cl2, giving 210 mg (96%) of a sticky
yellow solid.  1H NMR (CDCl3)  δ 7.01 (d, J = 8.0 Hz, 2H),
6.79 (d, J = 8.0 Hz, 2H), 5.95 (d, J = 7.2 Hz, 1H), 5.76 (m,
1H), 5.02 (d, J = 17.7 Hz, 1H), 4.97 (d, J = 12.3 Hz, 1H),
4.71 (m, 1H), 3.96 (t, J = 6.3 Hz, 2H), 3.00 (m, 2H), 2.44 (t,
J = 7.5 Hz, 2H), 2.35 (t, J = 9.0 Hz, 2H), 2.20 (s, 6H), 1.93
(m, 2H), 1.35 (s, 9H), 1.27 (m, 2H)  13C NMR (CDCl3):
171.3, 170.6, 157.7, 136.7, 130.2, 127.8, 115.3, 114,1,
82.0, 66.0, 56.3, 53.4, 45.5, 37.0, 35.6, 29.3, 27.9, 27.5.
4PO-TyrO3T(DMCm)-OtBu ( 1 5 ) .   762 mg 12  and
675 mg dimethoxycoumarinmethylbromide (DMCmBr) were
stirred overnight in 200 mL CH3CN at 60 °C under Ar.  After
rotoevaporation, the reaction mixture was purified by flash
chromatography on silica gel. First, starting material was
eluted using 1:1 petroleum ether / EtOAc with 5% MeOH, then
product was eluted with 7:1:1:1 EtOAc / MeOH / AcOH / H2O.
857 mg of an intensely yellow acetate salt were obtained in a
67% yield.  1H NMR (CDCl3)  δ 7.58 (s, 1H), 7.05 (d, J = 9.4
Hz, 2H), 6.86 (s, 1H), 6.78 (d, J = 9.6 Hz, 2H), 6.63 (s, 1H),
6.11 (d, J = 7.4 Hz, 1H), 5.79 (m, 1H), 5.20 (br s, 2H), 5.04
(d, J = 18.0 Hz, 1H), 4.99 (d, J = 10.0 Hz, 1H), 4.72 (m, 2H),
4.05 (t, J = 8.2 Hz, 2H), 3.96 (s, 3H), 3.94 (s, 3H), 3.88 (br
t, 2H), 3.30 (s, 6H), 3.01 (m, 2H), 2.35 (t, J = 7.8 Hz, 2H),
2.31 (m, 2H), 2.28 (m, 2H), 2.05 (s, 3H), 1.43 (s, 9H); 13C
NMR (CDCl3): 177.1, 171.6, 170.6, 159.6, 156.8, 153.6,
149.9, 147.0, 142.0, 136.6, 130.4, 128.9, 119.8, 115.4,
114.0, 111.1, 105.9, 100.1, 82.3, 64.0, 63.1, 62.2, 56.9,
56.4, 53.5, 51.0, 37.1, 35.5, 29.3, 28.0, 23.2, 22.1.
4PO-TyrO3T(DMCm)-OCH2CN (3).    857 mg 4PO-
TyrO3T(DMCm)-OtBu were dissolved in 25 mL methylene
chloride with. 5 mL TFA.  When reaction was complete,
volatiles were removed on the vacuum pump with a dry ice /
acetone trap.  15 mL anhydrous ClCH2CN and 1 mL
triethylamine were added to the flask, under argon. After
stirring overnight, the volatiles in the mixture were removed
on the vacuum pump with a dry ice/acetone trap.  The reaction
mixture was run on a column in 10:1:1:1 EtOAc / MeOH /
AcOH / H2O. acetate.  Collected fractions were rotovapped to
dryness, redissolved in minimal CH2Cl2, and extracted
against H2O to remove triethylamine salt.  651 mg of an
acetate salt, a 78% yield.  1H NMR (CDCl3)  δ 7.73 (s, 1H),
6.98 (d, J = 8.5 Hz, 2H), 6.79 (s, 1H), 6.70 (d, J = 8.5 Hz,
2H), 6.65 (s, 1H), 6.11 (d, J = 7.3 Hz, 1H), 5.77 (m, 1H),
5.44 (br s, 2H), 5.03 (d, J = 15.0 Hz, 1H), 4.97 (d, J = 10.5
Hz, 1H), 4.81 (m, 2H), 4.04 (t, J = 6.8 Hz, 2H), 4.02 (s, 3H),
4.00 (s, 3H), 3.96 (t, J = 6.7 Hz, 2H), 3.42 (s, 6H), 3.07 (m,
2H), 2.42 (m, 2H), 2.36 (m, 2H), 2.31 (m, 2H), 2.02 (s, 3H),
1.43 (s, 9H); 13C NMR (CDCl3): 177.1, 172.2, 170.2, 159.5,
157.9, 163.6, 149.8, 147.1, 141.8, 136.6, 130.1, 128.0,
120.2, 115.4, 114.5, 114.0, 111.0, 106.2, 100.0, 64.1,
63.5, 62.1, 57.6, 56.4, 53.2, 50.5, 48.8, 36.6, 25.0, 29.2.
General procedure for coupling of c y a n o m e t h y l
esters to dCA.  The dinucleotide was prepared as
previously reported2 with a few modifications: 1) the
dinucleotide coupling, oxidation, and deprotection with p-
toluenesulfonic acid were done in one pot; 2) the desalting of
dCA was accomplished by redissolving it in Millipore water,
freezing, and lyophilization to obtain a fluffy material; 3) the
tetrabutylammonium salt of the dinucleotide was formed by
mixing the proper amount 1 M N(n-Bu)4OH in MeOH with a
solution of dCA in water.  Freezing and lyophilization
provided a white fluffy solid which was then stored at -80 °C.
NVOC-TyrO3P(NVOC)-OdCA.  The synthesis of
NVOC-TyrO3P(NVOC)-OdCA is described as a general
procedure.  23 mg of dCA (tetrabutylammonium salt) were
dissolved in 0.5 mL anhydrous DMF, and were stirred with 53
mg NVOC-TyrO3P(NVOC)-OCH2CN (four equivalents)
dissolved in 0.5 mL anhydrous DMF in a 10 mL pear-shaped
flask, under argon. After 4 hours, a small amount of
tetrabutylammonium acetate was added using a metal spatula.
The reaction was monitored by analytical HPLC, using a
Waters NOVA-Pak C18 (150 x 3.9 mm) reverse-phase column
with a gradient from 25 mM NH4OAc (pH 4.5) to CH3CN.
When the reaction was judged complete after 24 hours, the
mixture was purified by semi-preparative HPLC with a Waters
NOVA-Pak C18 (300 x 7.8 mm) using a similar gradient. The
appropriate fractions were combined, frozen, and lyophilized
overnight. To remove ammonium ions, which inhibit T4
RNA ligase in the ligation of the product to tRNA, the
product was redissolved in 10 mM acetic acid, frozen, and
lyophilized again. This yielded 5.6 mg (6%; yields can be as
low as 1%) of the desired product as a pale yellow solid. Small
amounts of material were quantified by their UV-Vis spectra
in solution of 10 mM acetic acid, assuming ε350 = 6336 M-1
per nitroveratryl group. ESI+-MS: calculated for 755.7; found
[M+Na]+: 778.4.
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NVOC-Tyr-O3S(NVOC)-dCA.  Coupling procedure
differed in that N(n-Bu)4OAc salt was added to a cloudy
mixture of dCA in 500 µL DMF until dissolution was
complete and then this was combined with a 500 µL solution
of the cyanomethyl ester in DMF.  Reaction was complete
after 2 h.  2 mg obtained in a 5% yield. from 24 mg of
cyanomethyl ester and 32 mg dCA.  ESI+-MS: calculated for
C52H63N12O27P2+: 1349.3 ; found [M+H]+: 1349.3
4PO-TyrO3T(DMCm)-dCA.  Prepared by the general
coupling procedure.  After 36 h., reaction appeared to have
reached steady-state at ~ 60% completion.  6 mg obtained in a
31% yield. from 16 mg of cyanomethyl ester and 20 mg dCA.
Quantification was performed assuming ε350 = 13,000 M-1 for
the coumarin group.  ESI+-MS: calculated for C50H63N10O20P2+:
1185.4 ; found [M+]+: 1185.4
Note:   4PO-TyrO3T(DMCm)-dCA was originally
synthesized with a nitroveratryl (NV) protecting group on its
side-chain amine.  However, even after 1 h of photolysis
under the above conditions, no cleavage of the NV group was
observed, as detected by tandem HPLC electrospray MS
(positive ion, in 25 mM NH4OAc).  Photolysis of the model
compound N-NV-3-dimethylaminopropanol also failed, even
after 1 h of irradiation.  Deprotection of the DMCm-protected
3° amine, on the other hand, was complete after 5 - 10 min.
Unnatural amino suppression in X e n o p u s
oocytes.  The site-directed mutagenesis of the nAChR TAG
mutants, gene construction and synthesis of suppressor tRNA
and ligation of aminoacyl-dCA to tRNA have been described
previously2. Plasmid DNAs were linearized with NotI, and
mRNA was transcribed using the Ambion (Austin, TX) T7
mMESSAGE mMACHINE Kit.
Oocytes were removed from Xenopus laevis as described4
and maintained at 18 °C, in ND96 solution (96 mM NaCl/2
mM KCl/1.8 mM CaCl2/1 mM MgCl2/5 mM HEPES/2.5 mM
sodium pyruvate/0.5 mM theophyline/10 g/ml Gentamycin,
pH 7.5, with NaOH).  Before microinjection, the NVOC-
aminoacyl-tRNA was deprotected by irradiating the sample
for 5 or 10 min. with a 1000 W Hg/Xe arc lamp (Oriel)
operating at 400 W equipped with WG-335 and UG-11 filters
(Schott).  4PO-protected tRNA-aa was mixed 1:1 with a
solution of saturated I2 in water and allowed to sit for ten
minutes at room temperature.  Each oocyte was injected with a
1:1 mixture of deprotected aminoacyl-tRNA (25-50 ng) and
mRNA (12.5–18 ng of total at a concentration ratio of
20:1:1:1 for α:β:γ:δ subunits) in a volume of 50 nL.
Electrophysiological recordings.   Voltage-
clamped electrophysiological recordings were carried out 24-
72 hours after injection.  Whole-cell currents from oocytes
were measured using a Geneclamp 500 amplifier and pCLAMP
software (Axon Instruments, Foster City, CA) in the two-
electrode voltage-clamp configuration.  Microelectrodes were
filled with 3 M KCl and had resistances ranging from 1.0 to
2.5 MΩ.  Oocytes were continuously perfused with a
nominally Ca2+-free bath solution consisting of 96 mM
NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES (pH 7.5).
Microscopic ACh-induced and TMB-8 or QX-314-blocked
currents were recorded in response to bath application of ACh
and TMB-8 at a holding potential of -80 mV.  Low (5.5 - 6.5)
and high (8.5 and 9.0) pH solutions were of the same
composition as Ca2+-free bath with MES (low) or CHES
(high) substituted for HEPES buffer.  To ensure that changes
in buffer were not responsible for the observed changes in
channel conductance, recordings were taken at pH 7.0 and 8.0
in HEPES alongside recordings in MES and CHES.
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Figure A.  Primary Electrophysiological Data: TyrO3S, TyrO3T, and
TyrO3Q at α149: Tethered agonist responses to ACh, TMB-8, and
agonist-free solutions of varying pH.  Wild Type nAChR responses to
10 µM ACh at differing pHs.  Upper bars indicate agonist or blocker
application.  Lower bars indicate application of solution of given pH.
Arrows indicate blockable constitutive currents.
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Primary Electrophysiological Data:  Examples of
electrophysiological recordings for TyrO3S, TyrO3T, and
TyrO3Q suppressed at α149 are shown in Figure A.  For each
tethered agonist, there is a substantial standing current even
at pH 7.5, which can be blocked by TMB-8.  As seen in
previous tethered agonist studies, added ACh causes an
increase in current (followed by desensitization), indicating
that the tethers are "partial agonists."  For TyrO3S and
TyrO3T, application of low pH agonist-free solutions
potentiate constitutive activity by protonating the tether.
For TyrO3Q, which is always charged, changes in
constitutive activity with pH merely mirror the inherent
changes in channel conductance as seen for wild type
responses to 10 µM ACh at various pHs (Figure A, bottom).
TyrO3P:  The primary tether incorporates and gives
functional nAChRs, as seen by the response to ACh, but
shows no constitutive activity, even at pH 5.5. (Figure B)  It
would be surprising that the tether remains unprotonated, as
the pKa of aminopropanol is 10.2, higher than the 3° amine.5
TyrO3P may lack the steric bulk to activate the receptor.
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Figure B.  TyrO3P shows no constitutive activity.  TyrO3P and TyrO3T
at α149, their current responses to ACh, TMB-8, and pH 5.5.
α 149 Lys mutant:  No ACh-induced or TMB-8-
blockable currents were observed, and fluorescent labelling
studies with tetramethylrhodamine-conjugated bungarotoxin
(BuTx-TMR, an antagonist) showed no surface expression of
α149 Lys mutant nAChRs in oocytes.  Six days following
mRNA injection, oocytes were incubated (60 min, 4°C) in
ND96 solution containing BuTx-TMR (100 nM) and bovine
serum albumin (5 mg/ml).  After three washes with ND96 the
fluorescence intensity of the animal pole was determined
using an inverted epifluorescent microscope (IX-70 FLA;
Olympus Corp.) equipped with a photomultiplier tube
(R928P; Hamamatsu Photonics) attached to the side port.
This microscope (described previously, Li et al., 2000) was
fitted with an oil-immersion objective of 40X, NA 1.35.
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Figure C.  Fluorescent labelling of α149 Lys mutant nAChRs.
Tethered agonists at sites α 93 and γ5 5 / δ 57 .   As
stated earlier, the efficacy of a tethered agonist can be
evaluated in terms of the ratio of the constitutive current that
can be blocked by TMB-8 to the maximum current induced by
saturating concentrations of ACh.  An examination of the
efficacies of TyrO3S, TyrO3T, and TyrO3Q at α93 and
γ55/δ57 (Figures D and E) shows that all three tethers are less
potent at these sites than at α149.  TyrO3T and TyrO3Q
curves are similar in shape to the α149 curves.  Surprisingly,
although TyrO3S yields constitutive activity at all three
sites, it cannot be potentiated by pH at α93 and γ55/δ57.
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Figure D.  α93: Efficacy as a function of solution pH for tethered
agonists at α93.  Shown on the same scale as Figure 2 in main text.
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Figure E.  γ55/δ57: Efficacy as a function of solution pH for tethered
agonists at γ55/δ57.  Shown on the same scale as Figure 2 in main text.
TyrO3t-Bu, an uncharged analog of TyrO3Q in which the
quaternary nitrogen has been replaced by a carbon, also gave
weakly constitutively active receptors at α93 and γ55/δ57
(but not at α149).  TyrO3t-Bu showed no pH-dependent
potentiation over background.  This indicates that charge
may be less of a factor at these positions than at α149, and
may help to explain the puzzling TyrO3S behavior.
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